Ottawa Hospital Research Institute
Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and an affiliated institute of the University of Ottawa. It is one of the largest hospital-based research institutes in Canada, with a focus on understanding and developing innovative approaches to health care.
History[edit]
The Ottawa Hospital Research Institute was established in 2001, following the merger of three separate research facilities. The institute's roots can be traced back to the 1950s, when the first research laboratories were established at the Ottawa Civic Hospital.
Research[edit]
The Ottawa Hospital Research Institute conducts research in a wide range of areas, including cancer, heart disease, neuroscience, regenerative medicine, infectious disease, and epidemiology. The institute is organized into three research programs: Cancer Therapeutics, Chronic Disease, and Regenerative Medicine.
Cancer Therapeutics[edit]
The Cancer Therapeutics program focuses on developing new treatments for various types of cancer. This includes research into chemotherapy, radiation therapy, and immunotherapy.
Chronic Disease[edit]
The Chronic Disease program conducts research into diseases such as diabetes, heart disease, and respiratory disease. The goal of this program is to improve the prevention, diagnosis, and treatment of these diseases.
Regenerative Medicine[edit]
The Regenerative Medicine program focuses on developing new therapies that can repair or replace damaged tissues and organs. This includes research into stem cells, gene therapy, and tissue engineering.
Facilities[edit]
The Ottawa Hospital Research Institute is located in the Ottawa Health Sciences Centre, which also houses The Ottawa Hospital and the University of Ottawa's Faculty of Medicine. The institute's facilities include state-of-the-art laboratories, clinical research units, and a biobank.
Partnerships[edit]
The Ottawa Hospital Research Institute collaborates with a number of local, national, and international partners. These include the University of Ottawa, the Canadian Institutes of Health Research, and the Ontario Institute for Cancer Research.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
